Riva Alessandro
SEC CIK 1867172 · EDGAR
BoughtSold
Most active insiders at ONC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | OYLER JOHN | CEO, Dir | — | $327.88M |
| 2 | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | — | $13.37M |
| 3 | Wu Xiaobin | Pres, COO | — | $8.75M |
| 4 | Lee Chan Henry | SVP, GC | — | $7.95M |
| 5 | Wang Lai | Pres, Gbl Head of R, D | — | $1.17M |
| 6 | Sanders Corazon (Corsee) D. | Dir | — | $961.2K |
| 7 | Rosenberg Aaron | CFO | — | $524.4K |
| 8 | BAKER BROS. ADVISORS LP | Dir | — | $262.0K |
| 9 | Ball Titus B. | Principal Accounting Off | — | $127.3K |
| 10 | Dugan Margaret | Dir | — | $65.6K |
| 11 | Riva Alessandro | Dir | — | $65.6K |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-15 17:49 | 2026-06-11 | ONC | BeOne Medicines Ltd. | Riva Alessandro | Dir | A - Grant | $0.00 | +19.0K | 73.2K | +35% | $0 | |
| 2026-05-27 17:29 | 2026-05-22 | ONC | BeOne Medicines Ltd. | Riva Alessandro | Dir | S - Sale | $309.51 | -212 | 0 | -100% | -$65.6K | |
| D | 2026-01-06 | 2026-01-02 | BCYC | BICYCLE THERAPEUTICS PLC | Riva Alessandro | Dir | A - Grant | $0.00 | +7,380 | 19.9K | +59% | $0 |
| D | 2025-05-22 | 2025-05-21 | ONC | BeOne Medicines Ltd. | Riva Alessandro | Dir | A - Grant | $0.00 | +11.0K | 56.9K | +24% | $0 |
| D | 2025-03-27 | 2025-03-25 | BCYC | BICYCLE THERAPEUTICS PLC | Riva Alessandro | Dir | A - Grant | $0.00 | +12.5K | 12.5K | New | $0 |
| D | 2024-06-07 | 2024-06-05 | ONC | BeOne Medicines Ltd. | Riva Alessandro | Dir | A - Grant | $0.00 | +16.3K | 46.0K | +55% | $0 |
| D | 2023-06-20 | 2023-06-15 | ONC | BeOne Medicines Ltd. | Riva Alessandro | Dir | A - Grant | $0.00 | +12.9K | 29.6K | +77% | $0 |
| D | 2022-06-24 | 2022-06-22 | ONC | BeOne Medicines Ltd. | Riva Alessandro | Dir | A - Grant | $0.00 | +16.7K | 16.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations